Geneva, Switzerland, April 24, 2024 (GLOBE NEWSWIRE) —
SEALSQ’s semiconductor technology provides secure, reliable, and intuitive functionality for a wide array of medical applications.
SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced its technology strategy and solutions for IoMT security for medical and healthcare sectors.
SEALSQ is leading the charge in providing state-of-the-art security solutions tailored for the burgeoning Internet of Medical Things (IoMT) sector. By leveraging advanced semiconductor technology, SEALSQ ensures that IoT devices in medical and healthcare spheres maintain the highest security standards, essential for safeguarding sensitive patient data.
One of SEALSQ’s latest chip innovations is the VaultIC408, a secure element that boasts a FIPS 140-3 certified firmware running on a CCEAL5+ level Tamper Resistant hardware platform. This element is fundamental in protecting critical IoMT applications such as home patient monitoring hubs and modules. VaultIC408 design prioritizes efficient operation with minimal reliance on external components, streamlining integration into various applications.
SEALSQ’s secure element can be pre-provisioned at wafer level or on package to meet the flexibility and security needs of IoMT. Once provisioned, SEALSQ’s chips embed private keys and certificates aligned with standards like MATTER, Wi-SUN, and OPC. This benefits the device makers by cost effectively reducing their time-to-market and simplifying interoperability across devices.
To support the lifecycle of IoMT devices, SEALSQ offers a fully-fledged PKI-as-a-Service platform, called IneS™. This platform offers both factory and cloud-based provisioning and is highly scalable. It offers Zero touch automated device registration with cloud services like Azure or AWS while providing manufacturers with an intuitive web interface for the generation and management of certificates compliant with industry standards.
In the realm of IoMT, SEALSQ’s solutions are pivotal as the healthcare industry embraces the digital revolution. From on-body patient devices like smartwatches, diabetes care units, and hearing aids to home medical monitors and hospital diagnostic tools, the company’s semiconductor technology provides secure, reliable, and intuitive functionality for a wide array of medical applications.
SEALSQ takes pride in its role as a trailblazer, shaping a future where medical science is empowered by unparalleled security and cutting-edge technology. With the IoMT sector evolving rapidly, SEALSQ stands ready to deliver solutions that are at the forefront of medical and healthcare advancements, ensuring both the progress of healthcare services and the protection of patient data.
About SEALSQ:
SEALSQ focuses on selling integrated solutions based on Semiconductors, PKI and Provisioning services, while developing Post-Quantum technology hardware and software products. Our solutions can be used in a variety of applications, from Multi-Factor Authentication tokens, Smart Energy, Smart Home Appliances, Medical and Healthcare and IT Network Infrastructure, to Automotive, Industrial Automation and Control Systems.
Post-Quantum Cryptography (PQC) refers to cryptographic methods that are secure against an attack by a quantum computer. As quantum computers become more powerful, they may be able to break many of the cryptographic methods that are currently used to protect sensitive information, such as RSA and Elliptic Curve Cryptography (ECC). PQC aims to develop new cryptographic methods that are secure against quantum attacks. For more information, please visit www.sealsq.com.
Forward-Looking Statements
This communication expressly or implicitly contains certain forward-looking statements concerning SEALSQ Corp and its businesses. Forward-looking statements include statements regarding our business strategy, financial performance, results of operations, market data, events or developments that we expect or anticipates will occur in the future, as well as any other statements which are not historical facts. Although we believe that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates which are inherently subject to significant uncertainties and contingencies, many of which are beyond our control. Actual results may differ materially from those expressed or implied by such forward-looking statements. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include the expected success of our technology strategy and solutions for IoMT Security for Medical and Healthcare sectors, SEALSQ’s ability to implement its growth strategies, SEALSQ’s ability to continue beneficial transactions with material parties, including a limited number of significant customers; market demand and semiconductor industry conditions; and the risks discussed in SEALSQ’s filings with the SEC. Risks and uncertainties are further described in reports filed by SEALSQ with the SEC.
SEALSQ Corp is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
| SEALSQ Corp. Carlos Moreira Chairman & CEO Tel: +41 22 594 3000 info@sealsq.com | SEALSQ Investor Relations (US) The Equity Group Inc. Lena Cati Tel: +1 212 836-9611 / lcati@equityny.com Katie Murphy Tel: +212 836-9612 / kmurphy@equityny.com |
